Angiology | Medical XPRT
News
-
Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE Transcarotid Stent System
Silk Road Medical, Inc.?(Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that that the U.S. Food and Drug Administration (FDA) approved expanded indications for the ENROUTE stent to include ...
First Ever Standard Surgical Risk Patient TCAR Data to be Presented at the Society for Vascular Surgery 2021 Vascular Annual Meeting
Silicon Valley-Based Silk Road Medical Announces Expansion to MSP Region
Study Published in JAMA Finds Hospital Availability of TCAR Associated with an Improvement in Overall Outcomes for Carotid Revascularization
Equipment & Solutions
-
Showcase
Transcarotid Neuroprotection System
The ENROUTE Transcarotid Neuroprotection System provides direct carotid access with robust flow reversal prior to crossing the lesion for embolic protection during angioplasty and stenting. The device removes micro and macro emboli throughout the intervention for CEA-like neuroprotection in a less invasive approach.